MOLINA HEALTHCARE INC (MOH) Forecast, Price Target & Analyst Ratings

NYSE:MOH • US60855R1005

Current stock price

135.24 USD
-4.17 (-2.99%)
At close:
135.24 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MOLINA HEALTHCARE INC (MOH).

Forecast Snapshot

Consensus Price Target

Price Target
$156.67
+ 15.84% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 22, 2026
Period
Q1 / 2026
EPS Estimate
$2.54
Revenue Estimate
10.959B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
65.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$156.67
Upside
+ 15.84%
From current price of $135.24 to mean target of $156.67, Based on 24 analyst forecasts
Low
$110.09
Median
$147.90
High
$235.20

Price Target Revisions

1 Month
-12.12%
3 Months
-10.16%

Price Target Summary

24 Wall Street analysts provided a forecast for the next 12 months for MOH. The average price target is 156.67 USD. This implies a price increase of 15.84% is expected in the next year compared to the current price of 135.24.
The average price target has been revised downward by 10.16% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MOH Current Analyst RatingMOH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

MOH Historical Analyst RatingsMOH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
65.00%
MOH was analyzed by 24 analysts. The buy percentage consensus is at 65. So analysts seem to be rather neutral about MOH.
In the last month the buy percentage rose by 9 points. So the trust of analysts is improving.
MOH was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-12MizuhoMaintains Outperform -> Outperform
2026-03-12UBSMaintains Neutral -> Neutral
2026-03-04Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2026-02-20Wells FargoDowngrade Overweight -> Equal-Weight
2026-02-17Truist SecuritiesMaintains Hold -> Hold
2026-02-12Goldman SachsMaintains Neutral -> Neutral
2026-02-10BarclaysMaintains Underweight -> Underweight
2026-02-09TD CowenMaintains Hold -> Hold
2026-02-09Cantor FitzgeraldMaintains Neutral -> Neutral
2026-01-07Wells FargoMaintains Overweight -> Overweight
2026-01-05BarclaysMaintains Underweight -> Underweight
2025-11-12Wells FargoMaintains Overweight -> Overweight
2025-10-24Cantor FitzgeraldMaintains Neutral -> Neutral
2025-10-24UBSMaintains Neutral -> Neutral
2025-10-24BarclaysDowngrade Equal-Weight -> Underweight
2025-10-24Goldman SachsMaintains Neutral -> Neutral
2025-10-14Goldman SachsInitiate Neutral
2025-10-14Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-10-07Wells FargoMaintains Overweight -> Overweight
2025-09-05BernsteinMaintains Outperform -> Outperform
2025-09-04BarclaysMaintains Equal-Weight -> Equal-Weight
2025-08-26Cantor FitzgeraldReiterate Neutral -> Neutral
2025-08-15Wells FargoMaintains Overweight -> Overweight
2025-07-29JP MorganMaintains Neutral -> Neutral
2025-07-25Cantor FitzgeraldDowngrade Overweight -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 22, 2026
Period
Q1 / 2026
EPS Estimate
$2.54
Revenue Estimate
10.959B
Revenue Q2Q
-1.69%
EPS Q2Q
-58.15%
Number of Analysts
19

Next Earnings Revisions

Revenue (1 Month)
-1.68%
Revenue (3 Months)
-6.19%
EPS (1 Month)
-29.26%
EPS (3 Months)
-41.87%

Next Earnings Summary

MOH is expected to report earnings on 4/22/2026. The consensus EPS estimate for the next earnings is 2.54 USD and the consensus revenue estimate is 10.96B USD.
The next earnings revenue estimate has been revised downward by 6.19% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MOH revenue by date.MOH revenue by date.
34.072B
6.56%		40.65B
19.31%		45.426B
11.75%		44.565B
-1.90%		46.921B
5.29%		49.231B
4.92%		53.802B
9.28%		55.356B
2.89%		58.85B
6.31%		61.921B
5.22%		65.389B
5.60%
EBITDA
YoY % growth
MOH ebitda by date.MOH ebitda by date.
1.785B
10.53%		1.894B
6.11%		979M
-48.31%		759.31M
-22.44%		902.25M
18.82%		1.301B
44.20%		2.31B
77.56%		2.552B
10.48%		2.347B
-8.03%		2.761B
17.64%		2.927B
6.01%
EBIT
YoY % growth
MOH ebit by date.MOH ebit by date.
1.614B
12.16%		1.708B
5.82%		784M
-54.10%		519.15M
-33.78%		683.4M
31.64%		1.037B
51.74%		2.188B
110.99%		1.985B
-9.28%		2.028B
2.17%		2.427B
19.67%		2.574B
6.06%
Operating Margin
MOH operating margin by date.MOH operating margin by date.
4.74%4.20%1.73%1.16%1.46%2.11%4.07%3.59%3.45%3.92%3.94%
EPS
YoY % growth
MOH eps by date.MOH eps by date.
20.89
16.64%		22.65
8.43%		10.65
-52.98%		7.78
-26.98%		10.99
41.31%		15.62
42.15%		26.99
72.79%		28.42
5.28%		32.32
13.74%		41.20
27.47%		43.89
6.55%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		2.54
-58.15%		2.29
-58.21%		3.01
63.86%		2.06
174.82%		5.17
103.02%		4.69
104.87%		3.78
25.21%		3.04
47.64%
Revenue
Q2Q % growth		10.959B
-1.69%		11.156B
-2.37%		11.954B
4.16%		11.734B
3.16%		12.45B
13.61%		12.59B
12.85%		12.747B
6.63%		12.393B
5.62%
EBITDA
Q2Q % growth		247.69M
-48.72%		213.76M
-55.47%		290.84M
0.99%		216.7M
556.67%		482.51M
94.80%		389.19M
82.07%		265.19M
-8.82%		209.48M
-3.33%
EBIT
Q2Q % growth		179.98M
-58.63%		178.16M
-52.36%		227.65M
66.17%		157.75M
197.38%		454.51M
152.53%		361.55M
102.94%		237.44M
4.30%		182.45M
15.66%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.62%
EPS Next 5 Year
21.69%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.94%
Revenue Next 5 Year
4.17%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
6.70%
EBIT Next 5 Year
18.96%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MOLINA HEALTHCARE INC / MOH Forecast FAQ

Can you provide the average price target for MOLINA HEALTHCARE INC stock?

24 analysts have analysed MOH and the average price target is 156.67 USD. This implies a price increase of 15.84% is expected in the next year compared to the current price of 135.24.

When does MOLINA HEALTHCARE INC (MOH) report earnings?

MOLINA HEALTHCARE INC (MOH) will report earnings on 2026-04-22, after the market close.

What are the consensus estimates for MOLINA HEALTHCARE INC (MOH) next earnings?

The consensus EPS estimate for the next earnings of MOLINA HEALTHCARE INC (MOH) is 2.54 USD and the consensus revenue estimate is 10.96B USD.

What is the consensus rating for MOLINA HEALTHCARE INC (MOH) stock?

The consensus rating for MOLINA HEALTHCARE INC (MOH) is 65 / 100 . This indicates that analysts generally have a neutral outlook on the stock.